New developments in understanding the etiology of Parkinson's disease and in its treatment
- 1 December 1998
- journal article
- review article
- Published by Elsevier in Current Opinion in Neurobiology
- Vol. 8 (6) , 783-790
- https://doi.org/10.1016/s0959-4388(98)80122-0
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- The neurotoxin 1-methyl-4-phenylpyridinium is sequestered within neurons that contain the vesicular monoamine transporterNeuroscience, 1998
- Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine neurotoxicityProceedings of the National Academy of Sciences, 1998
- Hypothesis: The role of dopaminergic transporters in selective vulnerability of cells in Parkinson's diseaseAnnals of Neurology, 1998
- Mutations in the parkin gene cause autosomal recessive juvenile parkinsonismNature, 1998
- Models of Basal Ganglia Function and Pathophysiology of Movement DisordersNeurosurgery Clinics of North America, 1998
- A homeodomain gene Ptx 3 has highly restricted brain expression in mesencephalic dopaminergic neuronsProceedings of the National Academy of Sciences, 1997
- α-Synuclein in Lewy bodiesNature, 1997
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997
- Does the calcium binding protein calretinin protect dopaminergic neurons against degeneration in Parkinson's disease?Brain Research, 1994
- Three-dimensional computer reconstruction of midbrain dopaminergic neuronal populations: From mouse to manJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1983